HK1211919A1 - 抗病毒化合物的合成 - Google Patents

抗病毒化合物的合成

Info

Publication number
HK1211919A1
HK1211919A1 HK15112626.0A HK15112626A HK1211919A1 HK 1211919 A1 HK1211919 A1 HK 1211919A1 HK 15112626 A HK15112626 A HK 15112626A HK 1211919 A1 HK1211919 A1 HK 1211919A1
Authority
HK
Hong Kong
Prior art keywords
synthesis
antiviral compound
antiviral
compound
Prior art date
Application number
HK15112626.0A
Other languages
English (en)
Inventor
Jared Wayne Evans
Shinji Fujimori
Grace M Huynh
Qi Liu
Martin Gerald Teresk
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Publication of HK1211919A1 publication Critical patent/HK1211919A1/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/20Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
HK15112626.0A 2012-08-17 2015-12-23 抗病毒化合物的合成 HK1211919A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261684543P 2012-08-17 2012-08-17
US13/801,039 US8759544B2 (en) 2012-08-17 2013-03-13 Synthesis of an antiviral compound
PCT/US2013/054405 WO2014028342A1 (en) 2012-08-17 2013-08-09 Synthesis of an antiviral compound

Publications (1)

Publication Number Publication Date
HK1211919A1 true HK1211919A1 (zh) 2016-06-03

Family

ID=50100499

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15112626.0A HK1211919A1 (zh) 2012-08-17 2015-12-23 抗病毒化合物的合成

Country Status (10)

Country Link
US (2) US8759544B2 (zh)
EP (1) EP2885294B1 (zh)
JP (1) JP6118412B2 (zh)
AU (1) AU2013302913B2 (zh)
CA (1) CA2882115A1 (zh)
ES (1) ES2613552T3 (zh)
HK (1) HK1211919A1 (zh)
PT (1) PT2885294T (zh)
TW (1) TW201420587A (zh)
WO (1) WO2014028342A1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8841340B2 (en) 2012-08-17 2014-09-23 Gilead Sciences, Inc. Solid forms of an antiviral compound
WO2016057931A1 (en) 2014-10-10 2016-04-14 The Research Foundation For The State University Of New York Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration
EP3454856A4 (en) 2016-05-10 2019-12-25 C4 Therapeutics, Inc. HETEROCYCLIC DEGRONIMERS FOR TARGET PROTEIN REDUCTION
EP3455218A4 (en) 2016-05-10 2019-12-18 C4 Therapeutics, Inc. C3 CARBON-BASED GLUTARIMIDE DEGRONIMERS FOR TARGET PROTEIN REDUCTION
WO2017197036A1 (en) 2016-05-10 2017-11-16 C4 Therapeutics, Inc. Spirocyclic degronimers for target protein degradation
JP7312882B2 (ja) 2020-03-31 2023-07-21 本田技研工業株式会社 情報表示装置

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5861421A (en) 1995-12-21 1999-01-19 Smithkline Beecham Corporation 4,4-(disubstituted) cyclohexan-1-one monomers and related compounds
US20020002199A1 (en) 1998-03-12 2002-01-03 Lone Jeppesen Modulators of protein tyrosine phosphatases (ptpases)
US20050119332A1 (en) 1998-03-12 2005-06-02 Lone Jeppesen Substituted thiophene compounds as modulators of protein tyrosine phosphatases (PTPases)
EP2206709A3 (en) 2001-06-11 2011-06-29 Virochem Pharma Inc. Thiophene derivatives as antiviral agents for flavivirus infection
WO2002100846A1 (en) 2001-06-11 2002-12-19 Shire Biochem Inc. Compounds and methods for the treatment or prevention of flavivirus infections
MXPA05006196A (es) 2002-12-10 2006-01-27 Virochem Pharma Inc Compuestos y metodos para el tratamiento o prevencion de infecciones por flavivirus.
KR101058696B1 (ko) 2002-12-10 2011-08-22 바이로켐 파마 인코포레이티드 후라비바이러스 감염의 치료 또는 예방을 위한 화합물과방법
DE10359791A1 (de) 2003-12-19 2005-07-21 Bayer Healthcare Ag Substituierte Thiophene
WO2005081954A2 (en) 2004-02-25 2005-09-09 Wyeth Inhibitors of protein tyrosine phosphatase 1b
JP2007531757A (ja) 2004-03-30 2007-11-08 カイロン コーポレイション 抗癌剤としての置換チオフェン誘導体
DE102005028077A1 (de) 2004-12-22 2006-07-13 Aicuris Gmbh & Co. Kg Alkinyl-substituierte Thiophene
DE102004061746A1 (de) 2004-12-22 2006-07-06 Bayer Healthcare Ag Alkinyl-substituierte Thiophene
AP2007004245A0 (en) 2005-05-13 2007-12-31 Virochem Pharma Inc Compounds and methods for the treatment or prevention of flavivirus infections
JP2009526794A (ja) 2006-02-15 2009-07-23 サノフィ−アベンティス 新規なアミノアルコール置換アリールチエノピリミジノン、それらの製造方法及び薬剤としてそれらの使用
EA201101492A1 (ru) 2006-11-15 2012-09-28 Вирокем Фарма Инк. Аналоги тиофена для лечения или предупреждения флавивирусных инфекций
JP2010510191A (ja) 2006-11-17 2010-04-02 スミスクライン ビーチャム コーポレーション 抗ウイルス剤としての2−カルボキシチオフェン誘導体
KR20110098779A (ko) 2008-12-03 2011-09-01 프레시디오 파마슈티칼스, 인코포레이티드 Hcv ns5a의 억제제
AU2010276441B2 (en) 2009-07-21 2015-07-02 Gilead Sciences, Inc. Inhibitors of Flaviviridae viruses
KR20120081123A (ko) 2009-09-09 2012-07-18 길리애드 사이언시즈, 인코포레이티드 플라비비리대 바이러스의 억제제
AU2010326225A1 (en) 2009-11-25 2012-06-07 Vertex Pharmaceuticals Incorporated 5-alkynyl-thiophene-2-carboxylic acid derivatives and their use for the treatment or prevention of flavivirus infections
ES2543105T3 (es) 2010-01-15 2015-08-14 Gilead Sciences, Inc. Inhibidores de virus flaviviridae
SG10201500298PA (en) 2010-01-15 2015-03-30 Gilead Sciences Inc Inhibitors of flaviviridae viruses
WO2012006070A1 (en) * 2010-06-28 2012-01-12 Vertex Pharmaceuticals Incorporated Compounds and methods for the treatment or prevention of flavivirus infections
AU2011276526A1 (en) 2010-06-28 2013-01-10 Vertex Pharmaceuticals Incorporated Compounds and methods for the treatment or prevention of Flavivirus infections
WO2012087596A1 (en) 2010-12-20 2012-06-28 Gilead Sciences, Inc. Combinations for treating hcv
EP2734515B1 (en) 2011-07-13 2015-11-04 Gilead Sciences, Inc. Thiophen-2-carboxylic acid derivatives useful as inhibitors of flaviviridae viruses
US8927741B2 (en) 2012-08-17 2015-01-06 Gilead Sciences, Inc. Synthesis of an antiviral compound
US8841340B2 (en) 2012-08-17 2014-09-23 Gilead Sciences, Inc. Solid forms of an antiviral compound

Also Published As

Publication number Publication date
TW201420587A (zh) 2014-06-01
JP2015530993A (ja) 2015-10-29
US8759544B2 (en) 2014-06-24
US20140051867A1 (en) 2014-02-20
ES2613552T3 (es) 2017-05-24
WO2014028342A1 (en) 2014-02-20
PT2885294T (pt) 2017-02-09
CA2882115A1 (en) 2014-02-20
US20140275570A1 (en) 2014-09-18
JP6118412B2 (ja) 2017-04-19
AU2013302913A1 (en) 2015-02-05
EP2885294B1 (en) 2016-11-30
US9045462B2 (en) 2015-06-02
AU2013302913B2 (en) 2017-03-16
EP2885294A1 (en) 2015-06-24

Similar Documents

Publication Publication Date Title
IL258327A (en) Synthesis of antiviral compounds
HK1245263A1 (zh) 抗病毒化合物
IL252345B (en) Intermediate compounds for the synthesis of antiviral compounds
HK1205127A1 (zh) 抗病毒化合物的固體形式
IL262055B (en) Synthesis of lactams
GB201421334D0 (en) Synthesis of aeizeolite
SG10201703451RA (en) Antiviral compounds
HK1211924A1 (zh) 抗病毒化合物的固體形式
IL228604A0 (en) Synthesis of 5-azacytidine
HK1211919A1 (zh) 抗病毒化合物的合成
HK1199454A1 (zh) 抗病毒化合物
EP2800747A4 (en) POLYMORPHY OF PERAMPANEL
ZA201503913B (en) Synthesis of zsm-5
HK1204618A1 (zh) 抗病毒化合物
HK1203355A1 (zh) '- '-去鐵硫素類似物的用途
EP2892529A4 (en) USES OF (-) - PERHEXILINE
HK1202876A1 (zh) 改進的合成
EP2809685A4 (en) ELECTROCHEMICAL SYNTHESIS OF CHLORO-CHITOSAN
EP2699241A4 (en) ANTIVIRAL COMPOUNDS
ZA201402374B (en) Antiviral compounds
IL233446A0 (en) Polymorphic forms of paramphenel
GB201310660D0 (en) Synthesis of nucleosides
GB201204587D0 (en) Prodrugs of guanidine compounds
GB201204589D0 (en) Prodrugs of guanidine compounds
ITMI20121668A1 (it) Sintesi di un intermedio di un composto antivirale